Fowl Cholera in Poultry: Pasteurella multocida Pathogenesis, Clinical Signs, Prevention, Control, and WOAH Classification
By Dr. Zubair Khalid, DVM, MS, PhD ·
Key Takeaways
- Fowl cholera, caused by Pasteurella multocida, is a highly contagious bacterial disease of poultry manifesting in peracute, acute, and chronic forms, leading to significant economic losses and classified as a notifiable disease by WOAH.
- Pathogenesis involves bacterial colonization, septicemia, and evasion of host defenses through virulence factors like the hyaluronic acid capsule and lipopolysaccharide (LPS), with host responses including inflammatory cytokine induction and cell death pathways in organs like the liver.
- Clinical signs range from sudden death in peracute cases to fever, depression, respiratory distress, and diarrhea in acute presentations, while chronic forms exhibit localized lesions such as arthritis and bursitis.
- Diagnosis relies on isolation and identification of P. multocida via culture and biochemical tests, with molecular methods like PCR and LAMP offering rapid and specific detection, complemented by serological assays and genotyping for epidemiological tracing.
- Prevention and control strategies emphasize strict biosecurity, effective vaccination using inactivated or live attenuated vaccines, and judicious antimicrobial therapy, though antimicrobial resistance and antigenic diversity of P. multocida present ongoing challenges.
- P. multocida exhibits significant genetic diversity, with avian isolates predominantly belonging to capsular serogroups A and F, and specific serovars (1, 3, 4, 5) frequently associated with outbreaks, complicating vaccine efficacy and epidemiological surveillance.
Introduction
Fowl cholera is a highly contagious bacterial disease of domestic and wild birds caused by Pasteurella multocida [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The disease manifests in peracute, acute, and chronic forms and is responsible for significant economic losses in poultry production worldwide [<a href="#ref-1">1</a>, <a href="#ref-3">3</a>]. P. multocida is a Gram-negative, facultatively anaerobic, non-motile coccobacillus that belongs to the family Pasteurellaceae [<a href="#ref-4">4</a>]. The pathogen exhibits a broad host range, including chickens, turkeys, ducks, geese, and numerous wild avian species [<a href="#ref-5">5</a>]. Fowl cholera is classified as a notifiable disease by the World Organisation for Animal Health (WOAH) due to its potential for rapid spread and high mortality in susceptible flocks [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. This article provides an exhaustive review of the pathogenesis, clinical presentation, diagnostic approaches, prevention and control strategies, and WOAH classification of fowl cholera, with emphasis on the molecular mechanisms of virulence and antimicrobial resistance.
Etiology and Taxonomy
Pasteurella multocida is subdivided into five capsular serogroups (A, B, D, E, F) based on capsular polysaccharide antigens and 16 somatic lipopolysaccharide (LPS) serovars (1 through 16) defined by the Heddleston scheme. Avian isolates predominantly belong to capsular serogroups A and F, with serovars 1, 3, 4, and 5 being most frequently associated with fowl cholera outbreaks [<a href="#ref-6">6</a>, <a href="#ref-7">7</a>]. The species is further classified into three subspecies: P. multocida subsp. multocida, P. multocida subsp. septica, and P. multocida subsp. gallicida. Genomic studies have revealed considerable diversity among avian isolates, with multilocus sequence typing (MLST) identifying numerous sequence types (STs) that vary by geographic region and host species [<a href="#ref-5">5</a>, <a href="#ref-8">8</a>]. For example, ST20 has been found to be widespread in Australian poultry farms and may also infect wild waterbirds [<a href="#ref-5">5</a>]. In China, ST129 and other types have been reported in ducks and chickens [<a href="#ref-9">9</a>]. The genetic diversity of P. multocida is further complicated by phase variation in glycosyltransferase genes, which can alter LPS structure and contribute to immune evasion [<a href="#ref-10">10</a>].
Pathogenesis
The pathogenesis of fowl cholera involves a complex interplay of bacterial virulence factors and host immune responses. Following inhalation or ingestion, P. multocida colonizes the upper respiratory tract and subsequently invades the bloodstream, leading to septicemia. The capsule, composed primarily of hyaluronic acid in serogroup A strains, is a critical virulence factor that confers resistance to phagocytosis and complement-mediated killing. The stringent response, mediated by the alarmone (p)ppGpp, negatively regulates capsule production, indicating that capsule expression is tightly controlled during infection [<a href="#ref-11">11</a>].
Lipopolysaccharide (LPS) is another major virulence determinant. The LPS outer core structure varies among strains and influences both virulence and immunogenicity [<a href="#ref-4">4</a>]. Mutations in LPS biosynthesis genes, such as pcgD and hptE, attenuate virulence in ducks, demonstrating the importance of the outer core in pathogenesis [<a href="#ref-12">12</a>]. Similarly, a heptosyltransferase mutant producing truncated LPS is attenuated in chickens. The LPS also contributes to serum resistance and induction of proinflammatory cytokines [<a href="#ref-4">4</a>].
Adhesins and outer membrane proteins facilitate attachment to host cells. The filamentous hemagglutinin B1 (FhaB1) and B2 (FhaB2) are involved in adherence, although FhaB1 may not be essential for pathogenesis in turkey poults [<a href="#ref-13">13</a>]. Outer membrane protein H (OmpH) is a major immunogen and plays a role in adhesion and invasion [<a href="#ref-14">14</a>]. The lipoprotein E (PlpE) has been identified as a protective antigen. Other virulence-associated genes include ptfA (encoding type 4 fimbriae), hgbA (hemoglobin-binding protein), and toxA (dermonecrotic toxin), though the latter is more commonly associated with porcine strains.
Once in the bloodstream, P. multocida triggers a robust inflammatory response. In chickens, infection induces necroptosis and apoptosis in the liver, mediated by receptor-interacting serine/threonine kinase 1 (RIPK1) and RIPK3 pathways [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>]. The bacterium also upregulates genes involved in iron acquisition, as iron restriction is a key host defense mechanism [<a href="#ref-17">17</a>]. Transcriptomic analyses have identified numerous genes expressed during growth in host tissues, including those encoding metabolic enzymes, stress response proteins, and virulence factors. Signature-tagged mutagenesis has revealed genes required for survival in chickens and mice, highlighting the multifactorial nature of virulence.
Coinfections with other pathogens can exacerbate disease. For example, concurrent infection with Mycoplasmoides gallisepticum has been associated with high mortality in commercial turkeys [<a href="#ref-18">18</a>]. Similarly, coinfection with Ascaridia galli may increase susceptibility to fowl cholera in free-range chickens. Immunosuppression, whether due to stress, malnutrition, or concurrent disease, also predisposes birds to severe infection.
Clinical Signs and Pathology
The clinical presentation of fowl cholera varies with the virulence of the strain, host species, and route of exposure. In peracute cases, birds may be found dead without premonitory signs, often with high mortality rates approaching 100% in susceptible flocks [<a href="#ref-1">1</a>]. Acute fowl cholera is characterized by fever, depression, anorexia, mucoid discharge from the mouth and nostrils, cyanosis of the comb and wattles, and diarrhea [<a href="#ref-1">1</a>, <a href="#ref-19">19</a>]. Respiratory signs such as dyspnea and rales may be present, especially in turkeys [<a href="#ref-2">2</a>, <a href="#ref-18">18</a>]. Chronic infection typically manifests as localized lesions, including swollen joints (arthritis), sternal bursitis, and torticollis due to otitis media or meningitis [<a href="#ref-2">2</a>, <a href="#ref-7">7</a>].
Gross pathological findings in acute cases include petechial hemorrhages on the heart, liver, and serosal surfaces; an enlarged, friable liver with multifocal necrotic foci; and splenomegaly [<a href="#ref-1">1</a>, <a href="#ref-19">19</a>]. The lungs may be congested and edematous. In chronic cases, caseous exudates are found in the joints, sinuses, and middle ear [<a href="#ref-2">2</a>]. Histologically, acute cases show fibrinoid necrosis of hepatic sinusoids, myocardial degeneration, and bacterial emboli in multiple organs [<a href="#ref-16">16</a>]. The liver lesions are characterized by coagulative necrosis and infiltration of heterophils and macrophages [<a href="#ref-15">15</a>, <a href="#ref-16">16</a>].
In ducks, fowl cholera presents similarly, with high mortality and septicemic lesions [<a href="#ref-9">9</a>, <a href="#ref-20">20</a>, <a href="#ref-21">21</a>]. Turkeys are particularly susceptible, and outbreaks can result in sudden death with minimal gross lesions [<a href="#ref-6">6</a>, <a href="#ref-18">18</a>]. Japanese quail are also susceptible, with reports of infectious septicemia. The disease can cause acute heart rupture in backyard turkeys, leading to hemopericardium [<a href="#ref-19">19</a>].
Diagnosis
Definitive diagnosis of fowl cholera relies on isolation and identification of P. multocida from clinical specimens. Samples from acutely affected birds should include liver, spleen, lung, bone marrow, and heart blood. The organism grows readily on blood agar or tryptic soy agar under aerobic conditions, producing characteristic small, grayish, mucoid colonies with a sweet odor. Gram staining reveals Gram-negative coccobacilli. Biochemical tests confirm the identity, with positive reactions for oxidase, catalase, indole, and nitrate reduction.
Molecular diagnostics have largely replaced traditional methods for rapid and specific detection. PCR assays targeting the kmt1 gene (species-specific) or capsular typing genes are widely used [<a href="#ref-22">22</a>]. A 23S rRNA-based PCR assay provides high specificity for P. multocida identification. Loop-mediated isothermal amplification (LAMP) assays offer a field-deployable alternative with sensitivity comparable to PCR [<a href="#ref-23">23</a>]. Real-time PCR (5' Taq nuclease assay) enables quantification and detection in clinical samples. Fluorescent in situ hybridization (FISH) using rRNA probes can detect P. multocida directly in tissue sections.
Serological methods include indirect ELISA for detection of antibodies against OmpH or whole-cell antigens [<a href="#ref-24">24</a>, <a href="#ref-25">25</a>]. These assays are useful for monitoring vaccine responses and conducting serosurveys. However, serology cannot distinguish between infected and vaccinated animals (DIVA) unless specific markers are used.
Genotyping techniques such as MLST, pulsed-field gel electrophoresis (PFGE), and random amplified polymorphic DNA (RAPD) analysis are employed for epidemiological investigations [<a href="#ref-8">8</a>]. Whole-genome sequencing provides the highest resolution for outbreak tracing and identification of virulence and resistance genes [<a href="#ref-3">3</a>, <a href="#ref-5">5</a>, <a href="#ref-26">26</a>].
The following Mermaid diagram illustrates a diagnostic workflow for fowl cholera:
flowchart TD
A["Clinical suspicion: sudden death, septicemia, respiratory signs"] --> B["Postmortem examination"]
B --> C["Collect samples: liver, spleen, heart blood, bone marrow"]
C --> D["Gram stain & culture on blood agar"]
D --> E{"Typical colonies?"}
E -->|"Yes"| F["Biochemical identification: oxidase, catalase, indole"]
E -->|"No"| G["Consider other pathogens: Gallibacterium, E. coli, Salmonella"]
F --> H["Confirm with PCR: kmt1, capsular typing"]
H --> I["Antimicrobial susceptibility testing"]
I --> J["Genotyping: MLST, WGS for epidemiology"]
J --> K["Report and implement control measures"]Prevention and Control
Biosecurity and Management
Prevention of fowl cholera relies on strict biosecurity measures to prevent introduction and spread of P. multocida. The bacterium can be transmitted through direct contact with infected birds, contaminated feed and water, and fomites. Rodents, wild birds, and insects may serve as mechanical vectors [<a href="#ref-5">5</a>]. Free-range production systems pose a higher risk due to increased contact with wildlife. All-in-all-out management, proper sanitation, and control of vermin are essential. In outbreak situations, depopulation of affected flocks followed by thorough cleaning and disinfection is recommended [<a href="#ref-1">1</a>].
Vaccination
Vaccination is a cornerstone of fowl cholera control. Both inactivated (bacterins) and live attenuated vaccines are available. Bacterins provide serovar-specific protection and are commonly used in commercial layers and breeders [<a href="#ref-6">6</a>]. However, they may not protect against heterologous strains. Live attenuated vaccines, such as the PMZ8 strain developed by serial passage in ducks, offer broader cross-protection [<a href="#ref-27">27</a>]. Acapsular mutants have also been evaluated as live vaccine candidates.
Recombinant subunit vaccines targeting outer membrane proteins (OmpH, PlpE) and filamentous hemagglutinin (FhaB2) have shown promise in experimental settings [<a href="#ref-28">28</a>]. Flagellin has been used as an adjuvant to enhance immunogenicity of PlpE [<a href="#ref-28">28</a>]. DNA vaccines encoding OmpH have induced protective immune responses in chickens. Gamma-irradiated whole-cell vaccines, formulated with various adjuvants, have demonstrated safety and efficacy in chickens [<a href="#ref-29">29</a>, <a href="#ref-30">30</a>]. Hydrogel-based inactivated vaccines are also under investigation [<a href="#ref-31">31</a>]. In ducks, a combination vaccine containing live attenuated duck enteritis virus and recombinant OmpH of P. multocida provided protection [<a href="#ref-32">32</a>]. Intranasal administration of rOmpH vaccines has been shown to induce mucosal immunity.
Vaccine efficacy can be compromised by the emergence of new strains. Breakthrough outbreaks in vaccinated flocks have been documented, often associated with antigenic variation or the introduction of heterologous serovars [<a href="#ref-33">33</a>]. Therefore, autogenous vaccines prepared from local isolates are sometimes used [<a href="#ref-6">6</a>].
Antimicrobial Therapy and Resistance
Antimicrobial treatment is indicated in acute outbreaks to reduce mortality. Historically, tetracyclines, sulfonamides, and penicillin were effective, but resistance has become widespread [<a href="#ref-3">3</a>, <a href="#ref-22">22</a>]. Florfenicol has been used successfully in ducks, with pharmacokinetic studies showing adequate tissue concentrations [<a href="#ref-21">21</a>]. However, multidrug-resistant (MDR) strains are increasingly reported. In Bangladesh, P. multocida type B:2 isolates exhibited resistance to multiple antibiotic classes [<a href="#ref-34">34</a>]. Similarly, MDR strains have been isolated from poultry and rabbits in Egypt [<a href="#ref-22">22</a>]. In China, genomic characterization of avian P. multocida revealed a high prevalence of resistance genes, including those encoding beta-lactamases, tetracycline efflux pumps, and aminoglycoside-modifying enzymes [<a href="#ref-3">3</a>]. Plasmids carrying antimicrobial resistance genes have been characterized in avian isolates. The stringent response regulator Fis influences expression of virulence factors and may also affect susceptibility to certain antibiotics.
Antimicrobial susceptibility testing should guide therapy. The use of antibiotics in feed or water for prophylaxis is discouraged due to the risk of promoting resistance. Alternative strategies, such as probiotics, have shown potential in reducing mortality. A novel multi-strain probiotic significantly reduced fowl cholera mortality in broilers [<a href="#ref-35">35</a>]. Natural byproducts, such as plant extracts, have also demonstrated inhibitory effects on P. multocida growth and host cell interactions.
WOAH Classification
Fowl cholera is listed in the WOAH Terrestrial Animal Health Code as a notifiable disease. The WOAH classification requires member countries to report outbreaks of fowl cholera to facilitate international surveillance and trade restrictions. The disease is included in the WOAH list due to its potential for rapid spread, high morbidity and mortality, and economic impact on poultry industries [<a href="#ref-1">1</a>, <a href="#ref-2">2</a>]. The WOAH also provides guidelines for diagnostic testing, vaccine standards, and safe trade of poultry and poultry products. The classification underscores the importance of fowl cholera as a transboundary animal disease that requires coordinated control efforts.
Conclusion
Fowl cholera remains a major threat to poultry health worldwide. The pathogenesis of P. multocida is multifactorial, involving capsule, LPS, adhesins, and iron acquisition systems. Clinical signs range from peracute death to chronic localized infections. Diagnosis relies on culture, molecular methods, and genotyping for epidemiological tracking. Control strategies include biosecurity, vaccination, and judicious antimicrobial use, but the emergence of MDR strains and antigenic diversity pose ongoing challenges. The WOAH classification as a notifiable disease highlights the need for continued surveillance and research. Future efforts should focus on developing broadly protective vaccines, understanding the molecular basis of host specificity, and implementing integrated control programs that reduce reliance on antibiotics.